We were struck recently by a paper in Scientometrics that proposed a unique way to fund scientists: Distribute money equally, but require that each scientist donate a portion to others – turning the federal funding system into a crowd-sourcing venture that funds people instead of projects. The proposal could save the inordinate amount of time scientists … Continue reading What if scientists funded each other?
The week at Retraction Watch featured a look at whether we have an epidemic of flawed meta-analyses, and the story of a strange case involving climate research and pseudonyms. Here’s what was happening elsewhere:
Consider this: Fragments of a PLOS ONE paper overlap with pieces of other publications. The authors used them without credit and without quotation marks. This sounds an awful lot like plagiarism — using PLOS‘s own standards, even. But the journal isn’t calling it plagiarism. They’ve labeled this an instance of “text overlap,” a spokesperson told us, based … Continue reading When does “overlap” become plagiarism? Here’s what PLOS ONE decided
A journal has removed a paper after realizing it contained a verbatim quote from a patient that could reveal the patient’s identity. Reposting as our subscription software appears to be acting up again. Read the whole post here.
Climate scientists from the U.S. Department of Agriculture have withdrawn a study they wrote under eyebrow-raising pseudonyms. The withdrawn paper, about predicting surface temperatures of planets, appeared in Advances in Space Research in August, 2015, and is authored by Den Volokin and Lark ReLlez. Normally, a withdrawal wouldn’t raise our eyebrows, but climate scientist Gavin Schmidt pointed out on Twitter … Continue reading U.S. gov’t researchers withdraw climate paper after using pseudonyms
By all accounts, science is facing a crisis: Too many preclinical studies aren’t reproducible, leading to wasted time and effort by researchers around the world. Today in Cell Metabolism, Daniel Drucker at the Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital in Toronto details numerous ways to make this early research more robust. His most important advice: … Continue reading How can we improve preclinical research? Advice from a diabetes researcher
Reposting this as our email alerts seem to be down again. Read full post here.
Paolo Macchiarini — once a world-renowned surgeon for creating tracheas from cadavers and patients’ own stem cells – has been dogged for years by accusations of misconduct. Officials at his institution, Karolinska Institute, initially cleared him of many charges, but that all changed earlier this year, when Swedish Television (SVT) aired a series of documentaries about Macchiarini … Continue reading Meet the filmmakers who cracked open the case against star surgeon Macchiarini
This week at Retraction Watch featured the return of a notorious fraudster, and plagiarism of plagiarism. Here’s what was happening elsewhere:
Retraction Watch readers may recall the case of Piero Anversa and Annarosa Leri, both formerly of Harvard and the Brigham & Women’s Hospital in Boston. The pair — which has had their work subjected to a retraction, expression of concern, and correction — sued their former employers in 2014 for costing them job offers after … Continue reading Scientists investigated for misconduct lose appeal in suit against Harvard. Lawyers explain what it means.